SRNE

Sorrento Therapeutics, Inc.

Delisted

SRNE was delisted on the 22nd of February, 2023.

83 hedge funds and large institutions have $75.2M invested in Sorrento Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.57M
Puts
$1.15M
Net Calls
Net Calls Change

Top Buyers

1 +$7.53M
2 +$5.04M
3 +$2.38M
4
N
Nuveen
North Carolina
+$1.61M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.43M

Top Sellers

1 -$352K
2 -$333K
3 -$330K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$324K
5
Axa
Axa
France
-$210K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$308K
27
$277K
28
$250K
29
$226K
30
$218K
31
$209K
32
$207K
33
$206K
34
$201K
35
$199K
36
$193K
37
$191K
38
$190K
39
$160K
40
$157K
41
$141K
42
$134K
43
$123K
44
$117K
45
$115K
46
$114K
47
$111K
48
$109K
49
$102K
50
$99K